/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

A

Akihiro Tamiya

National Kinki Chuo Hospital for Chest Disease(JP)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

225

Papers

2.8K

Citations

29

h-index

64

i10-index

Akihiro Tamiya is an academic researcher from National Kinki Chuo Hospital for Chest Disease. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Research Studies. The author has an h-index of 29, co-authored 192 publications.

ORCID: 0000-0003-3599-2583

Research Topics

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Lung Cancer Research Studies Lung Cancer Diagnosis and Treatment Colorectal Cancer Treatments and Studies

Papers by this author

works

Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer

2019 · Scientific Reports · 35 citations

https://doi.org/10.1038/s41598-019-54804-9

Keiko Nakao Shinji Kobuchi Shuhei Marutani Ayano Iwazaki

Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCR

2017 · EBioMedicine · 17 citations

https://doi.org/10.1016/j.ebiom.2017.06.003

Masaru Watanabe Tomoya Kawaguchi Shun‐ichi Isa Masahiko Ando

Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes

2022 · BMC Cancer · 10 citations

https://doi.org/10.1186/s12885-022-10246-7

Koichi Sato Hiroaki Akamatsu Yasuhiro Koh Koichi Ogawa

The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLC

2021 · Scientific Reports · 6 citations

https://doi.org/10.1038/s41598-021-89006-9

Motohiro Tamiya Akihiro Tamiya Norio Okamoto Yoshihiko Taniguchi

A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan

2023 · JTO Clinical and Research Reports · 5 citations

https://doi.org/10.1016/j.jtocrr.2023.100508

Yasushi Goto Hirotsugu Kenmotsu Motohiro Tamiya Shuji Murakami

YAP Regulates HER3 Signaling–Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant Cancers

2024 · Clinical Cancer Research · 5 citations

https://doi.org/10.1158/1078-0432.ccr-24-1762

Yuki Katayama Tadaaki Yamada Keiko Tanimura Hayato Kawachi

Research topics

topics

Lung Cancer Treatments and Mutations

Cancer Immunotherapy and Biomarkers

Lung Cancer Research Studies

Lung Cancer Diagnosis and Treatment

Colorectal Cancer Treatments and Studies

Chat about Author

Papers

Chat

Click to start Chat